Bcl-xL Deamidation of Cancer Cells Correlates with Cisplatin-induced Cytotoxicity
碩士 === 國立陽明大學 === 醫學生物技術研究所 === 94 === Previous studies have shown that chemotherapy causes deamidation of the protein Bcl-xL in tumor cells. This Bcl-xL deamidation inhibits its antiapoptotic ability and sensitizes tumor cells to cisplatin treatment. Surprisingly, Rb inhibits this process. To test...
Main Authors: | Wei-Ting Cheng, 鄭瑋婷 |
---|---|
Other Authors: | I-Tsuen Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/99220643720983262007 |
Similar Items
-
Invovement ROS and NHE-1 in cisplatin-induced Bcl-xL deamidation in cancer cell
by: Shu-Fung Chang, et al.
Published: (2008) -
Cisplatin-Induced ROS and PI3K Inhibitor Contribute to Bcl-xL Deamidation in Human Lung Cancer Cells
by: Tung-Ting Chen, et al.
Published: (2011) -
Bcl-xL deamidation is involved in E1A-mediated sensitization to cisplatin in ovarian cancer cells
by: Ying-Mei Lin, et al.
Published: (2004) -
Control of cellular Bcl-xL levels by deamidation-regulated degradation.
by: So Hee Dho, et al.
Published: (2013-01-01) -
The Roles of Reactive Oxygen Species and DNA Repair in Bcl-xL Deamidation to Cancer Cells
by: Ya-Ping Li, et al.
Published: (2007)